Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
about
Data-mining technologies for diabetes: a systematic reviewTemporal data mining for the assessment of the costs related to diabetes mellitus pharmacological treatment.Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis.Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians.Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid StudyA 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.Quetiapine safety in older adults: a systematic literature review.Duloxetine and pregnancy outcomes: safety surveillance findingsPerformance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system.A plea for a more epidemiological and patient-oriented pharmacovigilance.Assessing cardiovascular drug safety for clinical decision-making.A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.Real-world risk of diabetes with antipsychotic use in older New Zealanders: a case-crossover study.Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker.Evaluation of disproportionality safety signaling applied to healthcare databases.
P2860
Q26863015-10324C1C-77DC-4400-8B73-E48B7507264BQ33547379-D7719BAD-9482-42BC-B40E-822AA20B18D3Q33915509-1662D54E-7DDE-444B-ADB8-0AE880DBB6E0Q34033259-38BCE6EE-FF57-4B28-BE97-F02FF86D8761Q34082230-7ABB94E2-7958-462F-90F1-C8E2295F104DQ35833294-2752A69C-31DF-4E2E-9CC6-50BE763F0DE4Q35905294-6D4CD951-9581-4062-8436-1E9D84901DF7Q36663394-19182C9C-D553-47A2-8CDE-11645A0143BAQ37378299-32F43241-2486-4C72-8CAC-A5120BC3A1BAQ37902956-FC1031BB-9181-469F-8528-095BDF8FD720Q38099504-FE6BFE69-7836-478C-9BFF-DA6C72A31F67Q38779921-7E0C7036-2C0F-4B9C-9D9C-B60E915BEE39Q40457990-DF75ABB9-5662-4212-8641-D5BA6F2A3B5AQ46828458-08819450-2000-4570-94CE-48D90E2DFB16Q53128866-B89050C0-7FD5-4CBF-B696-C953C94463B1
P2860
Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@ast
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@en
type
label
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@ast
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@en
prefLabel
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@ast
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@en
P2093
P1476
Antipsychotics, glycemic disor ...... reporting system (1968-2004).
@en
P2093
Amy L Grogg
David Fram
Krishnan Ramaswamy
Luella Engelhart
Ramy A Mahmoud
Xionghu Yang
P356
10.1080/10401230701844612
P577
2008-01-01T00:00:00Z